Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
NCNA NuCana
- 1.2500
- -0.0100-0.79%
Close Dec 3 16:00 ET
- 1.2600
- +0.0100+0.80%
Post 20:01 ET
4.91MMarket Cap-83P/E (TTM)
1.2860High1.2500Low68.11KVolume1.2700Open1.2600Pre Close86.15KTurnover2.10%Turnover RatioLossP/E (Static)3.93MShares19.410052wk High0.89P/B4.06MFloat Cap1.225052wk Low--Dividend TTM3.25MShs Float800.0000Historical High--Div YieldTTM2.86%Amplitude1.2250Historical Low1.2640Avg Price1Lot Size
About NuCana Company
NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.
Company Profile
SymbolNCNA
Company NameNuCana
Listing DateSep 28, 2017
Issue Price15.00
Founded1997
CEOMr. Hugh S. Griffith
MarketNASDAQ
Employees28
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address3 Lochside Way
CityEdinburgh
ProvinceMidlothian
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeEH12 9DT
Phone44-131-357-1111
Websitehttp://www.nucana.com
Company Executives
- Name
- Position
- Salary
- Hugh S. Griffith
- Chief Executive Officer and Director
- 974.59K
- Jeffrey Bloss, M.D.
- Chief Medical Officer
- --
- Donald Munoz
- Chief Financial Officer
- --
- Andrew Kay
- Non-Executive Chairman of the Board
- 78.77K
- Dr. Bali Muralidhar, M.D.,PhD
- Independent Director
- 52.67K
- Martin Christopher Bagot Mellish
- Independent Director
- 47.85K
- Cyrille Leperlier, M.D.
- Independent Director
- 65.08K
- Dr. Elliott M. Levy, M.D.
- Independent Director
- 54.23K
- Adam George
- Independent Director
- 56.56K
- David Harrison, M.D.
- Head, Translational Studies
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.